QPS Assay Finder
VALIDATED ASSAYS QPS
The vast majority of today’s modern bioanalytical methods for pharmacokinetics, pharmacodynamics, and immunogenicity assessment are based on mass spectrometry and/or immuno bioanalytical approaches. However, for a small but important number of compounds, LC MS/MS or LBA are less than satisfactory. A good alternative is Inductively Coupled Plasma Mass Spectrometry (ICP-MS). In ICP MS, the samples are ionized by an inductively coupled plasma (ionization source) and the ions of interest are separated, detected, and quantitated by a mass spectrometer.
The QPS Assay Finder contains a broad range of validated assays for all of your bioanalytical needs.
SEARCH FOR AN ASSAY HERE!
Found 835 Results
CYP3A4 (*1B, *2, *3) Genotyping (Matrix: Human Whole Blood)
| Matrix: | Human Whole Blood |
| Assay Range: | N.Ap. |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -80 |
| Platform: | Pyrosequencing |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Genomic Biomarkers |
CYP3A5 (*3C, *6) Genotyping (Matrix: Human Whole Blood)
| Matrix: | Human Whole Blood |
| Assay Range: | N.Ap. |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -80 |
| Platform: | Pyrosequencing |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Genomic Biomarkers |
Cystatin C (Matrix: Human Serum)
| Matrix: | Human Serum |
| Assay Range: | 3.12 – 50 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -70 |
| Platform: | ELISA |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
Cystatin C (Matrix: Human Urine)
| Matrix: | Human Urine |
| Assay Range: | 3.12 – 50 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -70 |
| Platform: | ELISA |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
Cystatin C (Matrix: Human Serum)
| Matrix: | Human Serum |
| Assay Range: | 0.156 – 3,000 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -70 |
| Platform: | ELISA |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
Cystatin C (Matrix: Human Urine)
| Matrix: | Human Urine |
| Assay Range: | 1.56 – 400 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -70 |
| Platform: | ELISA |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
Cystatin C (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 2 – 100 ng/mL |
| Sample Volume: | 0.01 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | ELISA |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
Cystatin C (Matrix: Human Urine)
| Matrix: | Human Urine |
| Assay Range: | 3.13 – 100 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -20 |
| Platform: | ELISA |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Genomic Biomarkers |
Cystatin C (Matrix: Human Serum)
| Matrix: | Human Serum |
| Assay Range: | 3.13 – 100 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -20 |
| Platform: | ELISA |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
Cytidine Deaminase, CDA(79A>C, 208G>A, 435C>T) Genotyping (Matrix: Human Whole Blood)
| Matrix: | Human Whole Blood |
| Assay Range: | N.Ap. |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -80 |
| Platform: | Pyrosequencing |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Oncology |
| Classification: | Genomic Biomarkers |
Cytokine Panel: MSD ProInflammatory 10-Plex (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | varies per cytokine |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -70 |
| Platform: | ECL (MSD) (10plex) |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
Cytokine Panel: MSD ProInflammatory 10-Plex (Matrix: Human CSF)
| Matrix: | Human CSF |
| Assay Range: | varies per cytokine |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -70 |
| Platform: | ECL (MSD) (10plex) |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
d-Amphetamine l-Amphetamine (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.1 – 100 ng/mL0.1 – 100 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Stimulant |
| Classification: | Drug Assays |
Dabigatran (Free) (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 1 – 300 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Dabigatran (Total) (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 1 – 500 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Daclatasvir (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 10 – 3000 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antiviral – HCV |
| Classification: | Drug Assays |
Dalteparin Sodium (anti-Factor IIa) (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 1.0 – 8.0 µg/mL |
| Sample Volume: | 0.025 mL |
| Anti-Coagulant: | Citrate |
| Storage Temperature (°C): | -70 |
| Platform: | Activity / Colorimetric |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Dalteparin Sodium (anti-Factor Xa) (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 1.0 – 10.0 µg/mL |
| Sample Volume: | 0.025 mL |
| Anti-Coagulant: | Citrate |
| Storage Temperature (°C): | -70 |
| Platform: | Activity / Colorimetric |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Cardiovascular |
| Classification: | Drug Assays |
Dapagliflozin in presence of Metformin (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 1 – 400 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC-MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Anti-diabetic |
| Classification: | Drug Assays |
Dapagliflozin in presence of Saxagliptin and 5-OH-saxagliptin (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 1 – 400 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Anti-diabetic |
| Classification: | Drug Assays |
Dapsone (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 5 – 5,000 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Antibiotic |
| Classification: | Drug Assays |
Dapsone
Dapsone Hydroxyamine (Matrix: Human Urine)
Dapsone Hydroxyamine (Matrix: Human Urine)
| Matrix: | Human Urine |
| Assay Range: | 50 – 3,000 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Antibiotic |
| Classification: | Drug Assays |
Dapsone
N-Acetyldapsone (Matrix: Human Plasma)
N-Acetyldapsone (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 10 – 3,000 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Antibiotic |
| Classification: | Drug Assays |
Dapsone
N-Acetyldapsone (Matrix: Human Plasma)
N-Acetyldapsone (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 10 – 3,000 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Antibiotic |
| Classification: | Drug Assays |
Darbepoetin Alpha (PK) (Matrix: Human Serum)
| Matrix: | Human Serum |
| Assay Range: | 125 – 4,000 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -70 |
| Platform: | ELISA |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Anemia |
| Classification: | Drug Assays |
DOWNLOAD THE FREE APPLE OR ANDROID APP HERE!
